April 1st 2024, 3:00pm
Treatment for HER2-positive breast cancer depends on staging and can be intensified or de-escalated depending on disease characteristics, explained Dr. Debu Tripathy.
March 27th 2024, 9:00pm
Comprehensive biomarker testing and “timely” testing is “important” for patients with a specific lung cancer subset, an expert said.
March 26th 2024, 9:00pm
Adding Keytruda to chemotherapy improved survival outcomes in patients with endometrial cancer, regardless of their mismatch repair or PD-L1 status.
March 25th 2024, 9:00pm
A phase 3 trial determined that Tivdak showed “game-changing results” for certain patients with cervical cancer, an expert told CURE®.
March 25th 2024, 1:00pm
Managing and mitigating long-term side effects in prostate cancer survivors are “really important,” as it affects quality of life, an expert said.
March 23rd 2024, 5:00pm
As part of its Speaking Out video series, CURE® spoke with Lillian Dugan of the Dear Jack Foundation about the needs of caregivers for adolescent and young adult patients with cancer.
As part of its Speaking Out video series, CURE® spoke with Lillian Dugan of the Dear Jack Foundation about the issues faced by adolescent and young adult patients with cancer as they age into adult care.
As part of its Speaking Out video series, CURE® spoke with Lillian Dugan of the Dear Jack Foundation about how a cancer diagnosis ‘adds a new identity’ for adolescent and young adult patients.
As part of its Speaking Out video series, CURE® spoke with Lillian Dugan of the Dear Jack Foundation about the power of mindfulness practices such as yoga and meditation.
As part of its Speaking Out video series, CURE® spoke with Lillian Dugan of the Dear Jack Foundation about the current landscape of research for adolescent and young adult patients with cancer.
Tecentriq, Cabometyx May Not Improve Survival Over Chemo in NSCLC
FDA Approves Ojemda for Pediatric Low-Grade Glioma
Woodpecker Wisdom Unfolds a Cancer Analogy
FDA Approves Lutathera for Pediatric GEP-NETs